GVR Report cover Moist Wound Dressings Market Size, Share & Trends Report

Moist Wound Dressings Market Size, Share & Trends Analysis Report By Product (Foam Dressings, Film Dressings), By Application (Acute Wounds, Chronic Wounds), By End Use (Hospitals, Home Healthcare), And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-2-68038-665-3
  • Number of Pages: 104
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2020
  • Industry: Healthcare

Report Overview

The global moist wound dressings market size was valued at USD 4.05 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.4% from 2022 to 2030. Wound dressings have evolved from simple dressings that cover the wound to advanced products that release pharmaceutically active ingredients for accelerating the healing process and reducing pain and inflammation. Wound care is essential to enhance the healing process and minimize the risk of associated infections. The rising incidence of diabetic pressure, venous stasis, and foot ulcers are one of the key factors driving the market.

U.S. moist wound dressings market size, by product, 2020 - 2030 (USD Billion)

The COVID-19 pandemic had a profound effect on the capacity of healthcare systems to keep up with curative and preventive services, particularly for the more vulnerable population. During the pandemic, the wound treatment centers in Italy managed a major reduction in the frequency of hospital admissions, since just urgencies, like extreme infections or wound hemorrhagic complexities, were permitted in the hospitals.

The COVID-19 pandemic affected the consultations by primary-care clinicians, hospitalization, and diagnostic workup for moist wound care management. The restrictions that were imposed by the pandemic did not weaken wound-related QOL or home care. Many healthcare organizations together with governments adopted telemedicine for wound care management, especially in cases of severe wounds as it helped in minimizing the risk of infection and reducing contact between physicians and patients. Although, in Germany, telemedicine had a negligible impact on wound care management, despite its obvious advantages in containing the risk.

Furthermore, the launch of novel therapies such as electromagnetic therapy, electrical stimulation, nanotechnology, and the use of silver and other combination dressings are boosting market growth. These advancements ensure better wound care and thus increase product adoption. A major advancement in the market includes the ability of these dressings to regulate moisture at the wound site, which aids in the regeneration of tissue and reduces infection and pain. Advanced products facilitate wound protection, gas exchange, antibacterial protection, thermal insulation, and exudate absorption, thereby boosting the market growth.

In addition, the growing incidence of burn injuries is projected to boost moist wound dressings demand. As per the statistics by the WHO, every year, about 180,000 deaths occur due to burning injuries. Moreover, the growing geriatric population across the globe is estimated to support market expansion. As per the WHO estimates, the global geriatric population (aged 60 years and above) is anticipated to reach about 2 billion by 2050.

This age group is susceptible to injuries and chronic wounds, such as venous leg and pressure ulcers, which is expected to spur the market growth in the years to come. Emerging regions such as Southeast Asia are expected to witness considerable growth on account of the rising cases of burn injuries. Growing disposable income, rising awareness regarding these dressing products, and the availability of better quality products in such regions are also contributing to the market growth.

Product Insights

The foam dressings segment held the largest revenue share of over 20.0% in 2021 in terms of revenue due to the soft and comfortable feel of these dressings. Moreover, they help prevent and stop exudation from burn injuries, which is also driving the segment. Due to their highly absorbent nature, these dressings can be changed after around 3-4 days and are used for wounds with heavy exudation without the complication of maceration.

According to the American Burn Association, approximately 450,000 patients are hospitalized due to burns each year and the risk of infection is higher in these patients. Based on product, the market is segmented into foam dressings, hydrocolloid dressings, film dressings, alginate dressings, hydrogel dressings, collagen dressings, and other advanced dressings. These wound dressings are recommended for chronic wounds like pressure and diabetic foot ulcers and burn injuries as they help create and maintain a moist environment, which facilitates a faster healing process.

Application Insights

The chronic wounds segment held the largest revenue share of over 55.0% in 2021. This can be attributed to the rising number of various chronic wounds. For instance, according to new statistics by The British Diabetic Association, in 2021, around 4.1 million people in the U.K. were living with some type of diabetes, whereas 850,000 people were expected to be living with type 2 diabetes, which was yet to be diagnosed. Additionally, as per the NCBI, the annual incidence rate of diabetic foot ulcers is predicted to be around 2% - 5%. The lifetime risk of diabetic foot ulcers is projected to be 15% - 20%. Therefore, as a result of the above-mentioned factors, the chronic wound segment is expected to dominate the market during the forecast period.

The acute wounds segment is anticipated to be the fastest-growing application segment due to the increasing prevalence of the disease and related complications. Due to the availability of advanced wound dressing products, such ulcers can be treated and healed quickly while reducing hospital stays and overall costs.

End-use Insights

The hospital's segment captured the largest revenue share of over 40.0% in 2021 and this trend is projected to continue over the forecast period. This growth can be primarily attributed to the rising number of surgeries performed in these settings. On the basis of end-use, the market can be categorized into hospitals, specialty clinics, home healthcare, and others.

Global moist wound dressings market share, by end use, 2021 (%)

The hospital segment is also driven by the increasing prevalence of chronic diseases and wounds. In addition, the high prevalence of hospital-acquired infections is anticipated to further drive the segment. The home care settings segment is anticipated to register a growth rate of 6.1% over the forecast period.

Regional Insights

North America held the largest revenue share of over 45.0% in 2021 owing to the presence of the target population and increased patient awareness levels. The market is estimated to expand further due to the increasing cases of chronic wounds, such as diabetic foot and pressure ulcers, in the region. As per the CDC, around 2.5 million patients suffer from pressure ulcers annually. The easy availability of products as a result of the presence of major market players and their wide distribution network will also contribute to the regional market growth.

The Asia Pacific is expected to witness lucrative growth over the forecast period as this region holds potential growth opportunities for the market. Moreover, the presence of emerging nations like Thailand, Malaysia, and Singapore is anticipated to fuel market growth.

Key Companies & Market Share Insights

Frequent merger and acquisition activities are observed in the market, mainly to gain a competitive edge. For instance, in December 2017, Medline Industries entered into an agreement with Resource Optimization & Innovation (ROI). This agreement is anticipated to provide Medline the access to ROi’s products. Companies are also focusing on the development of advanced products to attract more customers.

Some prominent players in the global moist wound dressing market include:

  • 3M Healthcare

  • Coloplast A/S

  • Medline Industries, Inc.

  • Cardinal Health, Inc.

  • B. Braun Melsungen AG

  • Smith & Nephew PLC

  • ConvaTec Group PLC

  • Derma Sciences, Inc.

  • Systagenix Wound Management Ltd.

Moist Wound Dressings Market Report Scope

Report Attribute

Details

Market size value in 2022

USD 4.26 billion

Revenue forecast in 2030

USD 6.51 billion

Growth Rate

CAGR of 5.4% from 2022 to 2030

Base year for estimation

2021

Historical data

2018 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million/billion and CAGR from 2022 to 2030

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

Segments covered

Product, application, end use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Australia; South Korea; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE

Key companies profiled

3M Healthcare; Coloplast A/S; Medline Industries, Inc.; Cardinal Health, Inc.; B. Braun Melsungen AG; Smith & Nephew PLC; ConvaTec Group PLC; Derma Sciences, Inc.; Systagenix Wound Management Ltd.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global moist wound dressings market report based on product, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)

    • Foam Dressings

    • Hydrocolloid Dressings

    • Film Dressings

    • Alginate Dressings

    • Hydrogel Dressings

    • Collagen Dressings

    • Other Advanced Dressings

  • Application Outlook (Revenue, USD Million, 2018 - 2030)

    • Acute Wounds

      • Surgical & Traumatic Wounds

      • Burns

    • Chronic Wounds

      • Diabetic Foot Ulcers

      • Pressure Ulcers

      • Venous Leg Ulcers

      • Other Chronic Wounds

  • End-use Outlook (Revenue, USD Million, 2018 - 2030)

    • Hospitals

    • Specialty Clinics

    • Home Healthcare

    • Others

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • MEA

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon